Global Buclizine Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Hospital
Drug Store
Segment by Application
Antiallergic Agent
Histamine H₁-Receptor Antagonist
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Stuart Pharmaceuticals
Laboratorios Rocnarf
UCB
Mankind Pharma
Johnson and Johnson
Meider Pharma
Sanofi
MK Pharma
HUA Shin Chemical Pharmaceutical
Peili Pharmaceutical
Pfizer
Sinphar
Al Pharm

Table of Content
1 Buclizine Market Overview
1.1 Product Overview and Scope of Buclizine
1.2 Buclizine Segment by Type
1.2.1 Global Buclizine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hospital
1.2.3 Drug Store
1.3 Buclizine Segment by Application
1.3.1 Buclizine Sales Comparison by Application: (2021-2027)
1.3.2 Antiallergic Agent
1.3.3 Histamine H₁-Receptor Antagonist
1.4 Global Buclizine Market Size Estimates and Forecasts
1.4.1 Global Buclizine Revenue 2016-2027
1.4.2 Global Buclizine Sales 2016-2027
1.4.3 Buclizine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Buclizine Market Competition by Manufacturers
2.1 Global Buclizine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Buclizine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Buclizine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Buclizine Manufacturing Sites, Area Served, Product Type
2.5 Buclizine Market Competitive Situation and Trends
2.5.1 Buclizine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Buclizine Players Market Share by Revenue
2.5.3 Global Buclizine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Buclizine Retrospective Market Scenario by Region
3.1 Global Buclizine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Buclizine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Buclizine Market Facts & Figures by Country
3.3.1 North America Buclizine Sales by Country
3.3.2 North America Buclizine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Buclizine Market Facts & Figures by Country
3.4.1 Europe Buclizine Sales by Country
3.4.2 Europe Buclizine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Buclizine Market Facts & Figures by Region
3.5.1 Asia Pacific Buclizine Sales by Region
3.5.2 Asia Pacific Buclizine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Buclizine Market Facts & Figures by Country
3.6.1 Latin America Buclizine Sales by Country
3.6.2 Latin America Buclizine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Buclizine Market Facts & Figures by Country
3.7.1 Middle East and Africa Buclizine Sales by Country
3.7.2 Middle East and Africa Buclizine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Buclizine Historic Market Analysis by Type
4.1 Global Buclizine Sales Market Share by Type (2016-2021)
4.2 Global Buclizine Revenue Market Share by Type (2016-2021)
4.3 Global Buclizine Price by Type (2016-2021)
5 Global Buclizine Historic Market Analysis by Application
5.1 Global Buclizine Sales Market Share by Application (2016-2021)
5.2 Global Buclizine Revenue Market Share by Application (2016-2021)
5.3 Global Buclizine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Stuart Pharmaceuticals
6.1.1 Stuart Pharmaceuticals Corporation Information
6.1.2 Stuart Pharmaceuticals Description and Business Overview
6.1.3 Stuart Pharmaceuticals Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Stuart Pharmaceuticals Product Portfolio
6.1.5 Stuart Pharmaceuticals Recent Developments/Updates
6.2 Laboratorios Rocnarf
6.2.1 Laboratorios Rocnarf Corporation Information
6.2.2 Laboratorios Rocnarf Description and Business Overview
6.2.3 Laboratorios Rocnarf Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Laboratorios Rocnarf Product Portfolio
6.2.5 Laboratorios Rocnarf Recent Developments/Updates
6.3 UCB
6.3.1 UCB Corporation Information
6.3.2 UCB Description and Business Overview
6.3.3 UCB Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 UCB Product Portfolio
6.3.5 UCB Recent Developments/Updates
6.4 Mankind Pharma
6.4.1 Mankind Pharma Corporation Information
6.4.2 Mankind Pharma Description and Business Overview
6.4.3 Mankind Pharma Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mankind Pharma Product Portfolio
6.4.5 Mankind Pharma Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Corporation Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Johnson and Johnson Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 Meider Pharma
6.6.1 Meider Pharma Corporation Information
6.6.2 Meider Pharma Description and Business Overview
6.6.3 Meider Pharma Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Meider Pharma Product Portfolio
6.6.5 Meider Pharma Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 MK Pharma
6.8.1 MK Pharma Corporation Information
6.8.2 MK Pharma Description and Business Overview
6.8.3 MK Pharma Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 MK Pharma Product Portfolio
6.8.5 MK Pharma Recent Developments/Updates
6.9 HUA Shin Chemical Pharmaceutical
6.9.1 HUA Shin Chemical Pharmaceutical Corporation Information
6.9.2 HUA Shin Chemical Pharmaceutical Description and Business Overview
6.9.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 HUA Shin Chemical Pharmaceutical Product Portfolio
6.9.5 HUA Shin Chemical Pharmaceutical Recent Developments/Updates
6.10 Peili Pharmaceutical
6.10.1 Peili Pharmaceutical Corporation Information
6.10.2 Peili Pharmaceutical Description and Business Overview
6.10.3 Peili Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Peili Pharmaceutical Product Portfolio
6.10.5 Peili Pharmaceutical Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Buclizine Description and Business Overview
6.11.3 Pfizer Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Pfizer Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Sinphar
6.12.1 Sinphar Corporation Information
6.12.2 Sinphar Buclizine Description and Business Overview
6.12.3 Sinphar Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sinphar Product Portfolio
6.12.5 Sinphar Recent Developments/Updates
6.13 Al Pharm
6.13.1 Al Pharm Corporation Information
6.13.2 Al Pharm Buclizine Description and Business Overview
6.13.3 Al Pharm Buclizine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Al Pharm Product Portfolio
6.13.5 Al Pharm Recent Developments/Updates
7 Buclizine Manufacturing Cost Analysis
7.1 Buclizine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Buclizine
7.4 Buclizine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Buclizine Distributors List
8.3 Buclizine Customers
9 Buclizine Market Dynamics
9.1 Buclizine Industry Trends
9.2 Buclizine Growth Drivers
9.3 Buclizine Market Challenges
9.4 Buclizine Market Restraints
10 Global Market Forecast
10.1 Buclizine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Buclizine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Buclizine by Type (2022-2027)
10.2 Buclizine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Buclizine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Buclizine by Application (2022-2027)
10.3 Buclizine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Buclizine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Buclizine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer